Life Sciences 2026

INTRODUCTION Contributed by: Lincoln Tsang, Ropes & Gray LLP Ropes & Gray LLP is home to one of the world’s pre- eminent life sciences groups, with a global platform for innovators at every stage of the development life cycle. The firm’s collaborative approach – spanning more than 25 practice areas and touching all offices around the world – offers one of the largest and most experienced industry-specific teams, comprising more

than 300 lawyers, subject-matter experts and techni- cal advisers who deliver sophisticated transactional, regulatory, IP, and litigation and enforcement strate- gies to position industry innovators and investors for success. The Ropes & Gray team is sought after to lead clients in navigating the complex legal landscape in which the life sciences industry operates.

Contributing Editor

Lincoln Tsang heads Ropes & Gray LLP’s European life sciences practice. A former senior regulator, he received postgraduate training in toxicology and cancer pharmacology. Lincoln concentrates his practice on UK, EU

and cross-border regulatory compliance and enforcement, including litigation, internal investigations and public policy matters affecting the life sciences industry. Lincoln advises clients on R&D strategies, product life cycle management, product acquisition, and risk and crisis management. He also regularly represents clients before various regulatory bodies in a wide range of matters concerning medicines and medical devices, including clinical trials, product approval, advertising and promotion, manufacturing, safety vigilance, and health technology appraisal related to pricing and reimbursement decision-making.

Ropes & Gray LLP 60 Ludgate Hill London EC4M 7AW UK

Tel: +44 20 3201 1500 Fax: +44 0 3201 1501 Email: lincoln.tsang@ropesgray.com Web: www.ropesgray.com

5 CHAMBERS.COM

Powered by